公开(公告)号：DE69615676T2

公开(公告)日：2002-07-11

申请号：DE69615676

申请日：1996-03-25

Applicant: ABBOTT LAB

Inventor： SHEPPARD S ,  DAVIDSON K ,  SUMMERS B ,  CARRERA M

IPC: C07D403/12 ,  A61K31/435 ,  A61P7/02 ,  C07D471/04

Abstract: The present invention provides compounds of formula +TR and the pharmaceutically acceptable salts thereof which are potent antagonists of PAF and are useful in the treatment of PAF-related disorders including asthma, shock, respiratory distress syndrome, acute inflammation, transplanted organ rejection, gastrointestinal ulceration, allergic skin diseases, delayed cellular immunity, parturition, fetal lung maturation, and cellular differentiation.

公开(公告)号：DE69615676D1

公开(公告)日：2001-11-08

申请号：DE69615676

申请日：1996-03-25

Applicant: ABBOTT LAB

Inventor： SHEPPARD S ,  DAVIDSON K ,  SUMMERS B ,  CARRERA M

IPC: C07D403/12 ,  A61K31/435 ,  A61P7/02 ,  C07D471/04

Abstract: The present invention provides compounds of formula +TR and the pharmaceutically acceptable salts thereof which are potent antagonists of PAF and are useful in the treatment of PAF-related disorders including asthma, shock, respiratory distress syndrome, acute inflammation, transplanted organ rejection, gastrointestinal ulceration, allergic skin diseases, delayed cellular immunity, parturition, fetal lung maturation, and cellular differentiation.